Entropy Neurodynamics Limited
ENP
Classificação em ações
#26196
Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical... Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.
Preço da ação
$0.02468497
Última sincronização: 2026-07-30
Valor de mercado
$40.28M
Variação (1 dia)
0.00%
Variação (1 ano)
-56.08%
País
AU
Negociar Entropy Neurodynamics Limited (ENP)
Categoria
Healthcare
Capitalização de mercado de Entropy Neurodynamics Limited(ENP)
Valor de mercado: $40.28M
Em October 2026, Entropy Neurodynamics Limited tem uma capitalização de mercado de $40.28M. Isso faz com que Entropy Neurodynamics Limited seja a 26196th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Entropy Neurodynamics Limited de 2021 a 2026
ENP comparado com o topo de 5 mais populares stocks
